The conversation explores the science behind ibogaine, its possible role in addressing addiction and neurological injury, and the growing policy momentum around psychedelic research in the United States. Hubbard also discusses the legislative and clinical efforts underway to bring ibogaine into formal drug development trials, including the large-scale research initiative now underway in Texas.
Videos
Third Wave Podcast - Solutions for Opioid Addiction & Brain Injury
July 1, 2025
In this episode of The Psychedelic Podcast, host Paul F. Austin speaks with Bryan Hubbard about his work advancing research into ibogaine and other psychedelic-assisted therapies. Hubbard reflects on his transition from leading Kentucky’s Opioid Abatement Advisory Commission to helping launch major research initiatives aimed at studying ibogaine’s potential therapeutic applications.